Chondroitinase ABC-mediated plasticity of spinal sensory function

Area of Science:

• Neuroscience
• Spinal Cord Injury Research
• Regenerative Medicine

Background:

• Current spinal cord injury (SCI) therapeutics aim to promote axon growth and overcome inhibitory molecules in the central nervous system (CNS).
• These approaches may inadvertently affect intact neural pathways, with unclear functional consequences.
• The role of intact circuitry reorganization in functional restoration post-SCI remains largely undescribed.

Purpose of the Study:

• To investigate the hypothesis that reorganization of intact spinal circuitry contributes to functional recovery after SCI.
• To determine if targeting inhibitory molecules can enhance functional restoration through circuit reorganization.

Main Methods:

• Adult rats underwent unilateral cervical spared-root lesions, causing sensory deficits.
• Chondroitinase ABC (ChABC), an enzyme degrading chondroitin sulfate proteoglycans, was focally injected into the spinal cord.
• Behavioral tests and in vivo electrophysiological recordings were used to assess sensory function and neural pathway activity.

Main Results:

• Rats with cervical lesions showed significant sensory deficits for 4 weeks.
• ChABC treatment successfully restored sensory function after the lesion.
• Electrophysiological data confirmed that recovery was due to the reorganization of intact C7 primary afferent terminals, not regeneration of damaged axons.

Conclusions:

• Intact spinal circuits play a critical role in functional restoration following spinal cord injury.
• Therapeutic strategies targeting specific circuitry, like ChABC, can promote recovery by reorganizing existing pathways.
• Understanding these mechanisms may enable tailored interventions to enhance SCI recovery and minimize adverse effects on other neural pathways.